Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe

Clinical Infectious Diseases

Volumn 36, Issue 9, 2003, Pages 1144-1151

  Campbell, Thomas B ^a,c   Borok, Margaret ^b   White, Irene E ^a   Gudza, Ivy ^b   Ndemera, Buxton ^b   Taziwa, Albert ^b   Weinberg, Adriana ^a   Gwanzura, Lovemore ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HERPES VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; VIREMIA; VIRUS GENE; VIRUS REPLICATION; ZIMBABWE;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; ENDEMIC DISEASES; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; VARIATION (GENETICS); VIREMIA; ZIMBABWE;

EID: 0038556800     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374599     Document Type: Article

References (34)

1. Chokunonga E, Levy LM, Bassett MT, et al. AIDS and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS 1999; 13:2583-8.
2. Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 2000; 85:54-9.
3. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998; 72:1005-12.
4. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93:6641-6.
5. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71:715-9.
6. Decker LL, Shankar P, Khan G, et al. The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996; 184:283-8.
7. Kedes DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs: implications for potential therapy. J Clin Invest 1997;99:2082-6.
8. Neyts J, De Clercq E. Antiviral drug susceptibility of human herpesvirus 8. Antimicrob Agents Chemother 1997; 41:2754-6.
9. Medveczky MM, Horvath E, Lurid T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997; 11:1327-32.
10. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma. Science 1995; 267:1078-9.
11. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the multicenter AIDS cohort study. J Infect Dis 1996; 173:1477-80.
12. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996; 10:1101-5.
13. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA, and the Roche Ganciclovir Study Group. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 1999;340:1063-70.
14. Robles R, Lugo D, Gee L, Jacobson M. Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirus 1999; 20:34-8.
15. Mazzi R, Giuseppe P, Sarmati L, et al. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 2001; 15 :2061-2.
16. Renwick N, Halaby T, Weverling GJ, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998; 12:2481-8.
17. Gao S-J, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpes virus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335:233-41.
18. Jacobson LP, Jenkins FJ, Springer G, et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections of the incidence of Kaposi's sarcoma. J Infect Dis 2000; 181:1940-9.
19. Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 2001; 39:4269-73.
20. Campbell TB, Borok M, Gwanzura L, et al. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS 2000; 14:2109-16.
21. Krigel RL, Laubenstein LJ, Muggia FM. Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 1983; 67:531-4.
22. White IE, Campbell TB. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 2000; 38:1992-5.
23. Weinberg A, Spiers D, Ai GY, Long CM, Sun R, Tevere V. Evaluation of a commercial PCR kit for diagnosis of cytomegalovirus infection of the central nervous system. J Clin Microbiol 1998; 36 :3382-4.
24. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332:1181-91.
25. Zong JC, Ciufo DM, Alcendor DJ, et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999; 73:4156-70.
26. Cook PM, Whitby D, Calabro ML, et al. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. AIDS 1999; 13:1165-76.
27. Fouchard N, Lacoste V, Couppie P, et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 2000; 85:166-70.
28. Lacoste V, Judde J-P, Briere J, et al. Molecular epidemiology of human herpesvirus 8 in Africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread. Virology 2000; 278:60-74.
29. Lebbe C, Agbalika F, de Cremoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133:25-30.
30. Brambilla L, Boneschi V, Berti E, Corbellino M, Parravicini C. HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma. Lancet 1996; 347:1338.
31. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345:84-6.
32. Harrington W Jr, Sieczkowski L, Sosa C, et al. Activation of HHV-8 by HIV-1 tat. Lancet 1997; 349:774-5.
33. Chang J, Renne R, Dittmer D, Ganem D. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 2000; 266:17-25.
34. Varthakavi V, Browning PJ, Spearman P. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J Virol 1999; 73:10329-38.